CRIS Current Research Information System

PARCHI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.955
AS - Asia 13.319
EU - Europa 9.411
SA - Sud America 932
Continente sconosciuto - Info sul continente non disponibili 807
AF - Africa 609
OC - Oceania 26
Totale 40.059
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.622
SG - Singapore 3.612
VN - Vietnam 3.274
CN - Cina 3.210
GB - Regno Unito 2.320
IT - Italia 2.249
DE - Germania 1.191
HK - Hong Kong 1.014
SE - Svezia 664
BR - Brasile 656
FR - Francia 637
IN - India 583
UA - Ucraina 444
RU - Federazione Russa 443
BD - Bangladesh 344
KR - Corea 344
NL - Olanda 335
IE - Irlanda 333
JP - Giappone 252
FI - Finlandia 191
SC - Seychelles 179
CA - Canada 174
ZA - Sudafrica 170
EE - Estonia 137
CI - Costa d'Avorio 118
ID - Indonesia 116
AR - Argentina 108
JO - Giordania 80
MX - Messico 80
PH - Filippine 74
AT - Austria 67
IQ - Iraq 66
BG - Bulgaria 62
TR - Turchia 61
TH - Thailandia 57
CH - Svizzera 54
ES - Italia 52
EC - Ecuador 44
TG - Togo 42
BE - Belgio 40
DK - Danimarca 39
PL - Polonia 36
CO - Colombia 35
TW - Taiwan 31
PK - Pakistan 25
UZ - Uzbekistan 25
SA - Arabia Saudita 24
AU - Australia 22
VE - Venezuela 22
CL - Cile 20
NG - Nigeria 19
GR - Grecia 18
MA - Marocco 17
PY - Paraguay 17
CR - Costa Rica 16
LT - Lituania 16
MY - Malesia 16
IL - Israele 15
LB - Libano 15
TN - Tunisia 14
CZ - Repubblica Ceca 13
PE - Perù 13
IR - Iran 12
EG - Egitto 11
JM - Giamaica 11
UY - Uruguay 10
DZ - Algeria 9
KE - Kenya 9
AL - Albania 8
MD - Moldavia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
HN - Honduras 7
HU - Ungheria 7
NI - Nicaragua 7
RO - Romania 7
SV - El Salvador 7
OM - Oman 6
BA - Bosnia-Erzegovina 5
KZ - Kazakistan 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
AM - Armenia 4
AO - Angola 4
BH - Bahrain 4
GA - Gabon 4
GT - Guatemala 4
HR - Croazia 4
KH - Cambogia 4
PR - Porto Rico 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
BO - Bolivia 3
BS - Bahamas 3
BY - Bielorussia 3
ET - Etiopia 3
IS - Islanda 3
KG - Kirghizistan 3
KW - Kuwait 3
Totale 39.188
Salva come PNG Salva come JPEG
Città #
Singapore 2.508
Southend 1.986
Ashburn 1.458
Fairfield 1.227
Hong Kong 967
Chandler 795
Hefei 747
San Jose 723
Ho Chi Minh City 667
Houston 616
Woodbridge 615
Seattle 603
Dong Ket 580
Hanoi 554
Wilmington 550
Ann Arbor 522
Council Bluffs 515
Cambridge 469
Bologna 462
Princeton 424
Santa Clara 376
Beijing 352
Dallas 343
Boardman 338
Dublin 333
Seoul 300
Jacksonville 281
Lauterbourg 266
Los Angeles 241
Tokyo 207
Nanjing 177
New York 177
Westminster 173
Berlin 157
Milan 150
Padova 138
Turin 137
Buffalo 136
Redmond 134
Helsinki 128
Abidjan 118
Florence 100
Redondo Beach 99
Haiphong 97
Da Nang 94
Rome 90
Jinan 87
Shenyang 85
San Diego 84
Chicago 83
Bengaluru 82
Frankfurt am Main 81
Amman 80
Guangzhou 73
São Paulo 73
Changsha 67
Jakarta 66
Saint Petersburg 65
Des Moines 60
Phoenix 59
Sofia 57
Medford 56
Tianjin 56
Nuremberg 55
Shanghai 55
Hebei 52
Nanchang 52
Lappeenranta 50
London 49
Mülheim 49
Verona 45
Montreal 44
Lomé 42
Falls Church 41
San Francisco 41
Can Tho 39
Olalla 39
Brussels 37
Imola 37
Vienna 37
Toronto 36
Amsterdam 35
Hangzhou 33
Mexico City 32
Atlanta 31
Biên Hòa 31
Dearborn 30
Jiaxing 30
Zhengzhou 30
Boydton 29
Bern 27
Rimini 27
Yubileyny 27
Mahé 26
Hải Dương 25
Norwalk 25
Orem 25
Taiyuan 25
Baghdad 24
Copenhagen 24
Totale 24.680
Salva come PNG Salva come JPEG
Nome #
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. 522
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 420
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 361
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 309
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 300
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 297
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 285
Messenger RNA processing is altered in autosomal dominant leukodystrophy 281
Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy 270
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 264
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 258
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 247
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 245
A case of fatal familial insomnia in Africa. 244
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study 237
A CTNNA3 compound heterozygous deletion implicates a role for αT-catenin in susceptibility to autism spectrum disorder. 236
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 231
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 231
Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions 230
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 229
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 228
Maternally inherited genetic variants of CADPS2 are present in Autism Spectrum Disorders and Intellectual Disability patients. 219
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation 212
A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. 211
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 210
Age at onset in genetic prion disease and the design of preventive clinical trials 210
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by theCYP4X1gene 208
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 204
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 203
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants 201
"Agrypnia excitata'' in a case of sporadic Creutzfeldt-Jakob disease VV2 200
Clinical effects of Lewy body pathology in cognitively impaired individuals 199
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 197
Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: A single-center study 196
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 196
Coexistence of Both PrPSc Type 1 and 2 in sCJD: Does it Affect the Phenotype? 195
Quantifying prion disease penetrance using large population control cohorts 193
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance 193
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene. 192
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. 188
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies 188
Clinical Reasoning: Rapidly progressive dementia in a patient with HIV after an exotic journey 188
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 188
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease 187
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 186
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 185
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease 184
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum 183
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 183
Sporadic Creutzfeldt-Jakob Disease. 182
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 182
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 179
Narcolepsy is a common phenotype in HSAN IE and ADCA-DN 179
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 178
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 177
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 177
Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study 177
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. 176
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 176
Pearls & Oy-sters: rapidly progressive dementia: prions or immunomediated? 176
Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions 175
Distribution of Diffusivity Changes in Subcortical Deep Gray Matter in Prion Diseases 175
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 175
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 173
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 173
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 173
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. 172
PROTEIN AMYLOIDOSIS ASSOCIATED WITH A NOVEL STOP CODON MUTATION IN PRNP 168
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 168
Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. 167
Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. 167
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 166
Heterogeneity of truncated fragments distinct from PrP27-30 correlates with clinico-pathological subtypes of Creutzfeldt-Jakob disease 165
History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease 165
Early onset sleep disorders predict severity, progression and death in multiple system atrophy 165
Atypical neuropathological sCJD-MM phenotype with abundant white matter Kuru-type plaques sparing the cerebellar cortex. 164
Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study 164
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 164
Variably protease-sensitive prionopathy presenting within ALS/FTD spectrum 164
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. 164
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 164
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification 163
Transmission properties of atypical Creutzfeldt-Jakob disease: A clue to disease etiology? 163
Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease 163
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives 162
Iodine-123-meta-iodobenzylguanidine myocardial scintigraphy in isolated autonomic failure: Potential red flag for future multiple system atrophy 162
Rapidly Progressive Alzheimer’s Disease: Contributions to Clinical-Pathological Definition and Diagnosis 162
Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier 162
RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease 162
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. 161
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 160
Regional pattern of microgliosis in sporadic Creutzfeldt-Jakob disease in relation to phenotypic variants and disease progression 160
CSF SerpinA1 in Creutzfeldt–Jakob disease and frontotemporal lobar degeneration 160
Clinical value of novel blood-based tau biomarkers in Creutzfeldt–Jakob disease 159
Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias 159
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 158
Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt–jakob disease: An international study 158
Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases 158
Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis 157
Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study 157
Totale 19.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.555
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.361 0 137 248 179 347 209 86 354 177 309 729 586
2022/20233.873 430 489 161 486 284 284 141 217 679 100 392 210
2023/20241.223 74 185 109 131 131 142 54 112 47 103 75 60
2024/20255.048 207 793 376 361 625 264 386 127 113 416 230 1.150
2025/202614.681 1.256 1.598 1.531 1.118 1.469 748 1.400 587 2.415 1.151 815 593
2026/20271.240 737 503 0 0 0 0 0 0 0 0 0 0
Totale 40.059